Ascendis Pharma A/s · NASDAQ:ASND
Smith Scott Thomas bought 250 Ascendis Pharma A/s shares (Form 4)
Traded May 29, 2026 · Filed Jun 1, 2026
On May 29, 2026, Smith Scott Thomas (EVP & Chief Financial Officer) bought 250 Ascendis Pharma A/s shares at US$223.32 for US$55,830, leaving 4,267 shares. Filed Jun 1, 2026 (Form 4).
- Bought
- 250 shares
- Price
- US$223.32
- Value
- US$55,830
- Holding after
- 4,267 shares
- Trading plan
- No
- Role
- EVP & Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Ordinary Shares | Buy | 250 | US$223.32 | 4,267 | Direct |
Source
Related
- Ascendis Pharma A/s
- Smith Scott Thomas
- Ascendis Pharma A/s shareholders
- Form 4 · Smith Scott Thomas · Jun 2, 2026
- Form 4 · Bodenhoff Mads · Sep 9, 2026
- Form 4 · Holtug Lars · Sep 3, 2026
- Form 4 · Bienaime Jean Jacques · Aug 18, 2026
- Form 4 · Bienaime Jean Jacques · Jun 1, 2026
- Form 4 · Bienaime Jean Jacques · May 27, 2026